Metraipolis › archive › dc_c58cd40b62f8

A phase II randomized controlled trial of orally administered yeast-derived β-glucan for alleviating chemoradiotherapy-induced oral mucositis in… — Europe PMC PMID:41878529

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41878529
DOI
10.3389/fonc.2026.1775554
License (as archived)
solo-consultazione
Archived
2026-11-05T00:03:14.162Z
SHA-256 of the archived text
2f9fe4529738c4f3ada38000156d47d773d072dae2cf114aed420901b975d1e3
Stable URL of this page
https://metraipolis.com/documento/dc_c58cd40b62f8

How to cite

A phase II randomized controlled trial of orally administered yeast-derived β-glucan for alleviating chemoradiotherapy-induced oral mucositis in… — Europe PMC PMID:41878529 — Europe PMC (en), https://europepmc.org/article/MED/41878529 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c58cd40b62f8 (Metraipolis archive dc_c58cd40b62f8, sha256 2f9fe4529738c4f3ada38000156d47d773d072dae2cf114aed420901b975d1e3)
BibTeX
@misc{dcc58cd40b62f8,
  title = {A phase II randomized controlled trial of orally administered yeast-derived β-glucan for alleviating chemoradiotherapy-induced oral mucositis in… — Europe PMC PMID:41878529},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41878529},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c58cd40b62f8; sha256 2f9fe4529738c4f3ada38000156d47d773d072dae2cf114aed420901b975d1e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41878529. Agents can read the archived copy with the MCP tool read_document.